FDA Brief

Warning letters Drugs

FDA warning letter to

Vivid-Scientific LLC

High riskIssued Mar 3, 2025Posted Mar 11, 2025Center for Drug Evaluation and Research (CDER)

Vivid-Scientific LLC sold injectable fat-dissolving products online as unapproved new drugs without FDA-approved applications.

What happened

FDA reviewed Vivid-Scientific's website in January 2025 and found it offered LemonBottle Ampoule Solution, Lipo Lab PPC Solution, Neobella Extreme, and Deoxycholic Acid Booster for sale in the United States. FDA said website claims such as “FAT DISSOLVER” and “permanent fat removal” establish that the injectable products are intended as drugs. FDA said no approved applications are in effect for these products, so they are unapproved new drugs.

What FDA found

  1. The products are unapproved new drugs because no FDA-approved application is in effect for them.

    Federal Food, Drug, and Cosmetic Act (FD&C Act) sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
  2. Website claims make the products drugs intended to affect the structure or function of the body.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  3. The products are not generally recognized as safe and effective for the claimed uses, so they are new drugs.

    FD&C Act section 201(p), 21 U.S.C. 321(p)

What FDA wants

FDA asks Vivid-Scientific to notify it in writing within 15 working days of the specific steps taken to correct the violations, including an explanation and related documentation. If corrections cannot be completed in that time, the company must state the reason for delay and when it will finish.

Who should pay attention

  • clinics and med spas that buy injectable fat-dissolving products
  • online sellers of injectable cosmetic or lipolytic products
  • distributors that source unapproved injectable drug products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk